Metformin should still be first-line therapy for Diabetes

Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link to abstract – registration required for full text)

Meta-Analysis: Metformin Should Still Be First-Line Diabetes Therapy, Even with Newer Drugs Available – NEJM Journal Watch commentary (free)

Metformin Remains Best First-line Therapy for Type 2 Diabetes – Medscape commentary (free registration required)

Related Article

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes – Annals of Internal Medicine (free)